Lactosylceramide 24:1

Intervention

1 paper1 finding

  • 1 lab in 1 country
  • Funder: National Natural Science Foundation of China
  • Humans1

Outcomes

1

PI3K–AKT signalling

upin human cells1

1 study
  1. Lactosylceramide 24:1 activates PI3K–AKT signalling in human cells.

    Cellshepatocyte

    A gut microbiome-lipid axis in early pregnancy is associated with metabolic dysregulation and diabetes risk

    iMeta10 Aug 2026

More on PI3K–AKT signalling

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months